MS in Latinos: What Do We Know?


multiple sclerosis

Multiple Sclerosis (MS) is a chronic neurological disease that usually affects young adults of various races/ethnicities, including Latinos. However, compared to white people, there is less understanding of how the disease impacts the Latino community. Let’s explore more about MS, why less is known about MS in Latinos, and how Latinos can gain equal access to MS care. What Causes MS? Normally, our body’s immune system protects us from getting sick. But sometimes, our immune system can mistakenly attack parts of our own body. In MS, the immune system attacks myelin, a substance that coats nerve fibers, according to the National Institute of Neurologic Disorders and Stroke. Myelin can be found in our body’s central nervous system, which includes the brain, optic ...

Read More

Bilingual Videos: Why Clinical Trials Are Important for Latinos



Despite the ever-growing population of Latinos in the United States, only a very small percentage participate in clinical trials. Clinical trials are studies with volunteers that help researchers learn how to slow, manage, and treat different diseases. “This massive underrepresentation of Latinos in clinical trials makes it hard for researchers to develop new treatments for this group, which suffers a heavy burden of cancer, Alzheimer’s, and other diseases,” said Dr. Amelie Ramirez, director of the Salud America! program at UT Health San Antonio. Do you know what happens in a clinical trial? How can clinical trial help you and your friends, family, and community? Why is Latino participation in clinical trials important? Get answers and helpful resources in new bilingual ...

Read More

Watch Webinar: The Importance of Diverse Biospecimens and How Can Latinos Donate



When people donate biospecimens—blood, fluid, or tissue samples—it gives researchers the opportunity to better understand, treat, and prevent conditions from cancer to Alzheimer’s. So why don't Latinos donate? Find the answers at UT Health San Antonio's Zoom webinar — “The Importance of Diverse Biospecimens and How Can Latinos Donate” — at 10 a.m. CT on April 5, 2023. The webinar features experts from UT Health San Antonio, Genentech, and leaders and participants in the All of Us Research Program discussing how to increase diverse biospecimen donation and point to donation opportunities. This is a part of a webinar of a series, “Let’s Address Health Equity Together.” The series is a collaboration of the Salud America! program at the Institute for Health ...

Read More

Watch Webinar: Busting the Myths and Cultural Barriers to Clinical Trials



Some Latinos fear becoming a guinea pig. Others worry about cost or trust. But clinical trials can provide volunteers potentially life-saving treatments and help researchers learn how to manage and treat different diseases for their family and communities. UT Health San Antonio held a Zoom webinar — “Busting the Myths and Cultural Barriers to Clinical Trials” — at 11 a.m. CT on March 9, 2023. This webinar features health experts and real Latino clinical trial volunteers to help define clinical trials, bust several common cultural, social, and logistical myths about clinical trials, and share testimonials of trial participation. Panelists will also connect audience members with culturally relevant resources and available opportunities to participate in clinical trials ...

Read More

Unpacking Latino Genes to Find Answers for Alzheimer’s Disease



Researchers are exploring a genetic variant that could explain the higher rates of Alzheimer’s among Latinos living in Puerto Rico. This work – which is ongoing – could help fill a critical gap in Latino Alzheimer’s research and spark new treatments for dementia, according to researchers at the John P. Hussman Institute for Human Genomics at the University of Miami. “A genetic target, which drug companies are showing interest in, is twice as likely to be successful therapeutically than nongenetic targets,” Margaret Pericak-Vance, leader of the Hussman Institute, told NBC News. Let’s dive into the research and how it impacts Latinos! The Need for Genetic Research on Alzheimer’s among Latinos Latinos are 1.5 times more likely than their peers to have ...

Read More

Webinar Series: Let’s Address Health Equity Together


Webinar Series Let’s Address Health Equity Together

Health equity is where everyone has a fair, just opportunity to be healthier. How can we reach this ideal, especially as Latinos face health disparities rooted in systemic inequities in access to clinical trials, income, health care, food, housing, and discrimination? You're invited to a webinar series, "Let’s Address Health Equity Together," a collaboration of the Salud America! program at the Institute for Health Promotion Research at UT Health San Antonio, the Mays Cancer Center at UT Health San Antonio, and Genentech. The newest four-webinar series for 2023 is: 3/9/23: Busting the Myths and Cultural Barriers to Clinical Trials 4/5/23: Importance of Biospecimens: Who Is Collecting and How Can You Get Latinos to Donate? 6/27/23: How to Care for the Latino ...

Read More

Latinos, Help Researchers Understand How Social Factors Affect Rheumatoid Arthritis!


RA doc

Rheumatoid arthritis (RA) can be debilitating and place a significant burden on patients, their families, employers, and the government. While genetics and health inequities do play a role in the development and progression of RA, social issues, such as lack of family and friend support, can also play a role in the progression of the disease. Researchers at the National Institutes of Health (NIH) Clinical Center want to learn more about how social and genetic factors affect RA in Latinos, who often face social issues when it comes to health. You can help by participating in a clinical trial no matter where you live in the US! Rheumatoid Arthritis Study Qualifications To be eligible for this clinical trial, you must be age 18 or older and of Hispanic/Latino heritage. You may ...

Read More

Study: Phase 1 Cancer Treatment Clinical Trials May Offer More Benefits Than in Past


clinical trials phase 1

Clinical trials are studies with volunteers that help researchers learn how to slow, manage, and treat different diseases. There are four phases of clinical trials that each help scientists answer different questions. Phase 1 clinical trials are the first step in testing a new treatment in people. They focus on evaluating the safety, side effects, best dose, and timing of a new treatment, according to the National Cancer Institute (NCI). Phase 1 clinical trials usually include a small number of patients who have not been helped by other treatments. In the past, participants in phase 1 trials for cancer treatment generally had low tumor response rates. And, because phase 1 trials are focused on assessing safety of treatments, doctors have hesitated to refer patients to these ...

Read More

Help Researchers Learn More about Preventing Dementia, Disability, and Disease


Patient and doctor

If you’re age 75 or older, you should know about PREVENTABLE. PREVENTABLE – the Pragmatic Evaluation of events And Benefits of Lipid-lowering – is a clinical trial to help researchers understand if taking a statin, a drug commonly used to lower cholesterol in younger adults, is helpful for older adults, specifically when it comes to maintaining health by preventing dementia, disability, and heart disease. “We really don’t know how these drugs work in older adults,” according to the research team at UT Health San Antonio, including Dr. Sara Espinoza, principal investigator for the local study site. “Most, if not all, of the studies of statins have been done in much younger people, in their 50s and 60s, but studies in adults over 75 are rare.” The national study is ...

Read More